D-0096-2020 Class II Terminated
FDA drug recall D-0096-2020 was initiated by KRS Global Biotechnology, Inc on Sep 12, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Aug 19, 2021). Affected quantity: 246 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 9, 2019
- Initiation Date
- Sep 12, 2019
- Termination Date
- Aug 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 246 vials
Product Description
Sermorelin 9 mg / GHRP6, 5.4 mg / GHRP2, 5.4 mg, Vial For SC Use-Lyophilized, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321673589
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide
Code Information
All lots remaining within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0096-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026